UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016346 |
|---|---|
| Receipt number | R000018972 |
| Scientific Title | Dexamethasone, ifosfamide, carboplatin, and etoposide in treating patients with refractory lymphoblastic lymphoma. |
| Date of disclosure of the study information | 2015/02/14 |
| Last modified on | 2022/08/02 16:49:26 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/01/26 21:59:19 | ||
| 2 | Update | 2015/05/01 23:11:06 | Recruitment status Anticipated trial start date Last follow-up date |
|
| 3 | Update | 2016/02/26 09:25:09 | Institute Institute Institutions |
|
| 4 | Update | 2018/01/30 16:27:30 | Name of primary person or sponsor Organization Organization Organization Division Category of Funding Organization |
|
| 5 | Update | 2019/08/16 10:37:23 | Stratification Dynamic allocation |
|
| 6 | Update | 2019/08/16 10:58:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 7 | Update | 2019/08/16 11:15:36 | Date of IRB Last follow-up date Other related information Other related information |
|
| 8 | Update | 2022/04/08 19:34:58 | Organization Organization Organization Division Category of Funding Organization Co-sponsor Co-sponsor |
|
| 9 | Update | 2022/08/02 16:49:26 | Last follow-up date |
